Patents Assigned to OMNIX MEDICAL LTD.
  • Patent number: 10745452
    Abstract: The invention provides a peptide comprising: a core amino acid sequence, which is identical or similar to the amino acid sequence of a member of the Cecropin family in a combination with an antibiotic drug. The invention further provides methods of treating an infection, overcoming inherent or acquired resistance of a microorganism to an antibiotic agent or disinfecting a wound, the methods comprises administering the peptide in combination with the antibiotic drug to a subject in need thereof, wherein the peptide and the antibiotic drug are administered simultaneously or consecutively.
    Type: Grant
    Filed: August 7, 2017
    Date of Patent: August 18, 2020
    Assignee: OMNIX MEDICAL LTD.
    Inventors: Niv Bachnoff, Moshe Cohen-Kutner
  • Patent number: 10538559
    Abstract: The invention provides a peptide comprising: a core amino acid sequence, which is identical or similar to the amino acid sequence of a member of the Cecropin family. The invention further provides a nucleic acid sequence encoding the peptide and a vector comprising said nucleic acid. The invention further provides a pharmaceutical composition comprising said peptide or said nucleic acid. The invention further provides methods of treating an infection, overcoming inherent or acquired resistance of a microorganism to an antibiotic agent or disinfecting a wound, the methods comprises administering the peptide to a subject in need thereof.
    Type: Grant
    Filed: April 15, 2019
    Date of Patent: January 21, 2020
    Assignee: OMNIX MEDICAL LTD.
    Inventors: Niv Bachnoff, Moshe Cohen-Kutner
  • Patent number: 10308693
    Abstract: The invention provides a peptide comprising: a core amino acid sequence, which is identical or similar to the amino acid sequence of a member of the Cecropin family. The invention further provides a nucleic acid sequence encoding the peptide and a vector comprising said nucleic acid. The invention further provides a pharmaceutical composition comprising said peptide or said nucleic acid. The invention further provides methods of treating an infection, overcoming inherent or acquired resistance of a microorganism to an antibiotic agent or disinfecting a wound, the methods comprises administering the peptide to a subject in need thereof.
    Type: Grant
    Filed: February 17, 2016
    Date of Patent: June 4, 2019
    Assignee: OMNIX MEDICAL LTD.
    Inventors: Niv Bachnoff, Moshe Cohen-Kutner